Urea C 13

CHEMBL2096648 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
61.0 g/mol
LogP
-1.4
Phase
4

Urea C-13 is a stable isotope-labeled form of urea containing carbon-13, used primarily as a diagnostic agent in the 13C-urea breath test to detect active Helicobacter pylori infection in the gastrointestinal tract. After oral ingestion, H. pylori urease cleaves 13C-urea to produce 13CO2, which is detected in exhaled breath, providing a non-invasive, radiation-free diagnostic test. It is also used in metabolic research studies investigating urea cycle function and protein metabolism.

Peso Molecular

61,0480 g/mol

LogP

-1,40

TPSA

69,10 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Mecanismo de Ação

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N[13C](N)=O

InChI

InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)/i1+1

Molecular Formula

CH4N2O

HBD / HBA

2 / 1

Ligações Rotacionáveis

0

Átomos Pesados

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Urea C-13 is a stable isotope-labeled form of urea containing carbon-13, used primarily as a diagnostic agent in the 13C-urea breath test to detect active Helicobacter pylori infection in the gastrointestinal tract. After oral ingestion, H. pylori urease cleaves 13C-urea to produce 13CO2, which is detected in exhaled breath, providing a non-invasive, radiation-free diagnostic test. It is also used in metabolic research studies investigating urea cycle function and protein metabolism.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Urea C 13 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096648. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 636363. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.